BiotechTube
Home/Prokarium/Julia Jones, FCA
JJ

Julia Jones, FCA

Chief Financial Officer

Prokarium

Therapeutic Areas

Oncology

Prokarium Pipeline

DrugIndicationPhase
ZH9Non-Muscle Invasive Bladder Cancer (NMIBC)Phase 1
ZH9 + Checkpoint InhibitorsMuscle-Invasive Bladder Cancer (MIBC)Discovery/Preclinical
IO PrimeImmunotherapy Prime (Indication Agnostic)Preclinical/IND-enabling
Living Cures PlatformVarious Cancers (Cargo Delivery)Discovery

Leadership Team at Prokarium

IM
Ibs Mahmood
Chief Executive Officer
LD
Livija Deban, PhD
Chief Scientific Officer
DH
Dara Henry, PhD
Chief Operating Officer
JH
Josi Holz, MD, PhD
Chief Medical Officer
TE
Thomas Eldered
Chairman of the Board
View full Prokarium profile